Social Media in the Pharmaceutical Industry

Memo

Social media is the perfect channel for pharmaceutical companies to educate, market, listen and connect with customers, patients and physicians. How the pharmaceutical industry utilize social media is particularly complex as regulators such as the FDA have not yet written the rules about how pharmaceuticals can engage with potential customers and patients. Join SMi’s 11th annual Social Media in the Pharmaceutical Industry conference to learn the best way your company can benefit from a robust social media strategy. Hear from industry experts on how to leverage social media platforms by keeping the patient at the forefront and exploring the latest advances in digital application such as Artificial Intelligence, challenges and techniques in the field of ‘social pharma’. Network and learn from: - [CHAIR] - Jason Browning, Global Head of Digital Communications & Social Media, Novartis- [CHAIR] - Emma Sutcliffe, Director Patient Engagement and Innovation, NexGen Healthcare Communications- Roeland Van der Heiden, Digital Director, AstraZeneca- Lin Lei, Associate Director Digital Customer Engagement, Teva- Joao Bocas, CEO, DigitalSalutem- Paul Tunnah, CEO, PharmaPhorum Media- Jacob D Flindt, Founder, InforMed.pro- Alan Shaw, Director, Strategic Planet; Senior Lecturer: Digital Marketing, Northumbria University- Dennis Fink, Campaign Manager and Social Media Channel Expert, Qiagen- Stefania Alvino, Multichannel Manager, Daiichi Sankyo Co., Ltd. Featured Highlights: - Explore a result driven, value focused social media strategy in the pharmaceutical industry- Gain insight into procedures and practices required prior to the implementation of social listening- Discuss how to personalise the content relationships with AI- Understand the optimisation of disease awareness through social media channels- Learn how to use social networks and digital communication to engage HCPs- GDPR regulations and limitations to product advertisement (with case studies)